Myriad Publishes myPath™ Melanoma Pivotal Validation Study in the Journal of ...
Myriad Genetics, Inc. (NASDAQ: MYGN) today announced the Journal of Cutaneous Pathology published data from a pivotal clinical validation study that showed the myPath™ Melanoma test is highly effective at differentiating benign skin moles from ...
News-Medical.net - Thu, 05 Mar 2015 01:11



FTC Settles with Marketers of Two Melanoma Detection Apps
Last month, the Federal Trade Commission (FTC) announced settlements that prohibit the marketers of two mobile apps – “MelApp” and “Mole Detective” – from continuing to claim that their apps can detect symptoms of melanoma. According to the FTC, ...
The National Law Review - Thu, 05 Mar 2015 15:37

FTC raps US app marketers for claiming they could detect melanoma
CosmeticsDesign.com USA - Thu, 05 Mar 2015 07:22

FTC fines mobile app developer for misleading behavior
Lexology (registration) - Thu, 05 Mar 2015 02:41



Melanoma survivor urges lawmakers to bar minors from tanning beds
PHOENIX - Christine Nelson said there's a reason a tanning bed looks like a coffin. A melanoma survivor, Nelson said she has had numerous surgeries and takes eight doses of a chemotherapy drug every day. And she said it's all because she decided to add ...
Verde Independent - Thu, 05 Mar 2015 04:00



Sun damage causes genetic changes that predispose children and adolescents ...
The St. Jude Children's Research Hospital—Washington University Pediatric Cancer Genome Project found that melanoma in some adolescent and adult patients involves many of the same genetic alterations and would likely respond to the same therapy.
Medical Xpress - Wed, 04 Mar 2015 11:07

Sun damage predisposes pediatric patients to melanoma
Oncology Nurse Advisor - Thu, 05 Mar 2015 10:22

Study Shows Castle Biosciences' Noninvasive Skin Melanoma Gene Test ...
FRIENDSWOOD, Texas — Castle Biosciences, Inc. today announced the publication of a clinical study showing that its gene expression profile (GEP) test for cutaneous (skin) melanoma improved the prognostic accuracy of sentinel lymph node biopsy (SLNB) ...
Rock Hill Herald (press release) - Thu, 05 Mar 2015 08:30



FTC Targets App Marketers That Claim to Detect Melanoma
MelApp and Mole Detective were supposed to calculate a mole's risk of being melanoma as low, medium or high -- even in the early stages -- based on photos taken with a smartphone and information provided by the user. "App developers and marketers ...
NBCNews.com - Wed, 25 Feb 2015 10:29

FTC fines marketers of two apps that claim to detect melanoma
Washington Post (blog) - Mon, 23 Feb 2015 13:39

Can an app diagnose melanoma? It'll need proof, says FTC
Ars Technica - Mon, 23 Feb 2015 17:07

FTC fines two melanoma risk detection apps, MelApp and Mole Detective
MobiHealthNews - Mon, 23 Feb 2015 14:41

Feds crack down on melanoma detector apps
KHOU - Tue, 24 Feb 2015 09:48

Feds Warn: These Melanoma Detection Apps Aren't Supported By Scientific ...
The Consumerist - Mon, 23 Feb 2015 15:15

Ipilimumab Doubled 5-Year Survival in Advanced Melanoma
Patients with advanced melanoma who received front-line treatment with ipilimumab/dacarbazine had double the 5-year survival rate compared with patients treated with dacarbazine alone, according to the results of a survival analysis published in the ...
Cancer Network - Wed, 04 Mar 2015 08:07



Oncolytics Biotech (ONCY) Presents Encouraging REOLYSIN Data as Malignant ...
"Malignant melanoma is typically resistant to traditional chemotherapeutic and radiotherapy regimens," said Dr. Matt Coffey Chief Operating Officer of Oncolytics. "This preclinical research highlights the synergistic role REOLYSIN® could play in making ...
StreetInsider.com - Thu, 05 Mar 2015 03:26

Fantastic Four: Oncolytics Biotech Inc. (NASDAQ:ONCY), Altria Group Inc ...
eMarketsDaily - Fri, 06 Mar 2015 04:01


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014